EE05185B1 - Kompositsioonid p?letikuliste protsesside k„sitlemiseks - Google Patents

Kompositsioonid p?letikuliste protsesside k„sitlemiseks

Info

Publication number
EE05185B1
EE05185B1 EEP200100397A EEP200100397A EE05185B1 EE 05185 B1 EE05185 B1 EE 05185B1 EE P200100397 A EEP200100397 A EE P200100397A EE P200100397 A EEP200100397 A EE P200100397A EE 05185 B1 EE05185 B1 EE 05185B1
Authority
EE
Estonia
Prior art keywords
handling
compositions
inflammatory processes
inflammatory
processes
Prior art date
Application number
EEP200100397A
Other languages
English (en)
Estonian (et)
Inventor
M. Linden Joel
W. Sullivan Gail
J. Sarembock Ian
Macdonald Timothy
Okusa Mark
L. Kron Irving
Michael Scheld W.
Original Assignee
University Of Virginia Patent Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/333,387 external-priority patent/US6232297B1/en
Application filed by University Of Virginia Patent Foundation filed Critical University Of Virginia Patent Foundation
Publication of EE200100397A publication Critical patent/EE200100397A/xx
Publication of EE05185B1 publication Critical patent/EE05185B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/167—Purine radicals with ribosyl as the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EEP200100397A 1999-02-01 2000-01-31 Kompositsioonid p?letikuliste protsesside k„sitlemiseks EE05185B1 (et)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US11802999P 1999-02-01 1999-02-01
US12431699P 1999-03-12 1999-03-12
US13337499P 1999-05-10 1999-05-10
US13557399P 1999-05-24 1999-05-24
US09/333,387 US6232297B1 (en) 1999-02-01 1999-06-15 Methods and compositions for treating inflammatory response
US15141299P 1999-08-30 1999-08-30
PCT/US2000/002324 WO2000044763A2 (en) 1999-02-01 2000-01-31 Compositions for treating inflammatory response

Publications (2)

Publication Number Publication Date
EE200100397A EE200100397A (et) 2002-08-15
EE05185B1 true EE05185B1 (et) 2009-06-15

Family

ID=27557920

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100397A EE05185B1 (et) 1999-02-01 2000-01-31 Kompositsioonid p?letikuliste protsesside k„sitlemiseks

Country Status (26)

Country Link
EP (1) EP1150991B1 (zh)
JP (1) JP4837831B2 (zh)
KR (1) KR100668006B1 (zh)
CN (1) CN1191266C (zh)
AR (1) AR029332A1 (zh)
AT (1) ATE263777T1 (zh)
AU (2) AU778870B2 (zh)
BR (1) BR0007864A (zh)
CA (1) CA2361614C (zh)
CZ (1) CZ296404B6 (zh)
DE (1) DE60009665T2 (zh)
DK (1) DK1150991T3 (zh)
EE (1) EE05185B1 (zh)
ES (1) ES2215609T3 (zh)
HK (1) HK1047288A1 (zh)
HU (1) HU228937B1 (zh)
IL (2) IL144188A0 (zh)
MX (1) MXPA01007850A (zh)
MY (1) MY129445A (zh)
NO (1) NO321216B1 (zh)
NZ (1) NZ513096A (zh)
PL (1) PL199953B1 (zh)
PT (1) PT1150991E (zh)
SK (1) SK284877B6 (zh)
UA (1) UA72912C2 (zh)
WO (1) WO2000044763A2 (zh)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6448235B1 (en) 1994-07-11 2002-09-10 University Of Virginia Patent Foundation Method for treating restenosis with A2A adenosine receptor agonists
US6514949B1 (en) 1994-07-11 2003-02-04 University Of Virginia Patent Foundation Method compositions for treating the inflammatory response
US6232297B1 (en) 1999-02-01 2001-05-15 University Of Virginia Patent Foundation Methods and compositions for treating inflammatory response
US7427606B2 (en) 1999-02-01 2008-09-23 University Of Virginia Patent Foundation Method to reduce inflammatory response in transplanted tissue
US7378400B2 (en) 1999-02-01 2008-05-27 University Of Virginia Patent Foundation Method to reduce an inflammatory response from arthritis
US6322771B1 (en) * 1999-06-18 2001-11-27 University Of Virginia Patent Foundation Induction of pharmacological stress with adenosine receptor agonists
IL133680A0 (en) 1999-09-10 2001-04-30 Can Fite Technologies Ltd Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist
CA2460911C (en) * 2001-10-01 2011-08-30 University Of Virginia Patent Foundation 2-propynyl adenosine analogs having a2a agonist activity and compositions thereof
US20050033044A1 (en) 2003-05-19 2005-02-10 Bristol-Myers Squibb Pharma Company Methods for preparing 2-alkynyladenosine derivatives
CN1972945A (zh) * 2004-04-02 2007-05-30 腺苷治疗有限责任公司 A2a腺苷受体的选择性拮抗剂
US7396825B2 (en) * 2004-05-03 2008-07-08 University Of Virginia Patent Foundation Agonists of A2A adenosine receptors for treatment of diabetic nephropathy
US7442687B2 (en) 2004-08-02 2008-10-28 The University Of Virginia Patent Foundation 2-polycyclic propynyl adenosine analogs having A2A agonist activity
WO2006028618A1 (en) 2004-08-02 2006-03-16 University Of Virginia Patent Foundation 2-polycyclic propynyl adenosine analogs with modified 5'-ribose groups having a2a agonist activity
US7605143B2 (en) * 2004-08-02 2009-10-20 University Of Virginia Patent Foundation 2-propynyl adenosine analogs with modified 5′-ribose groups having A2A agonist activity
WO2007120972A2 (en) 2006-02-10 2007-10-25 University Of Virginia Patent Foundation Method to treat sickle cell disease
EP2021350B1 (en) 2006-03-21 2016-12-21 Rheinische Friedrich-Wilhelms-Universität Bonn Phosphorylated a2a receptor agonists
US8188063B2 (en) 2006-06-19 2012-05-29 University Of Virginia Patent Foundation Use of adenosine A2A modulators to treat spinal cord injury
US8058259B2 (en) 2007-12-20 2011-11-15 University Of Virginia Patent Foundation Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists
CA2729819C (en) * 2008-07-03 2014-08-26 University Of Virginia Patent Foundation Unit dosage of apadenoson
WO2011002917A1 (en) 2009-06-30 2011-01-06 Pgxhealth, Llc Alkoxy-carbonyl-amino-alkynyl-adenosine compounds and derivatives thereof as a2a r agonists
FR2960876B1 (fr) 2010-06-03 2012-07-27 Sanofi Aventis Derives de 3,4-dihydropyrrolo[1,2-a]pyrazine-2,8(1h)-dicarboxamide leur preparation et leur application en therapeutique.
CN114096552B (zh) * 2019-06-21 2024-09-27 中国人民解放军军事科学院军事医学研究院 具有a2a腺苷受体拮抗作用的小分子化合物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3537228A1 (de) * 1985-10-19 1987-04-23 Huels Chemische Werke Ag Verfahren zur herstellung von cyclohexylverbindungen
JPS6299330A (ja) * 1985-10-25 1987-05-08 Yamasa Shoyu Co Ltd 抗高血圧剤
WO1990005526A1 (en) * 1988-11-15 1990-05-31 Yamasa Shoyu Kabushiki Kaisha Agent for treatment and prophylaxis of ischemic disease of heart or brain
EP0429681B1 (en) * 1989-06-20 1995-09-06 Yamasa Shoyu Kabushiki Kaisha (Yamasa Corporation) Intermediate for 2-alkynyladenosine synthesis, production of said intermediate, production of 2-alkynyladenosine from said intermediate, and stable 2-alkynyladenosine derivative
WO1991009864A1 (en) * 1990-01-04 1991-07-11 Yamasa Shoyu Kabushiki Kaisha Drug for treating or preventing ischemic diseases of heart or brain
JPH03287537A (ja) * 1990-03-31 1991-12-18 Yamasa Shoyu Co Ltd 抗動脈硬化症剤
JP3025559B2 (ja) * 1990-07-19 2000-03-27 ヤマサ醤油株式会社 アデノシン誘導体
JP3025557B2 (ja) * 1991-06-28 2000-03-27 ヤマサ醤油株式会社 ２‐アルキニルアデノシン誘導体
JP3053908B2 (ja) * 1991-06-28 2000-06-19 ヤマサ醤油株式会社 ２‐アルキニルアデノシン誘導体
IT1254915B (it) * 1992-04-24 1995-10-11 Gloria Cristalli Derivati di adenosina ad attivita' a2 agonista
AU7449598A (en) * 1997-05-23 1998-12-11 Nippon Shinyaku Co. Ltd. Medicinal composition for prevention or treatment of hepatopathy
WO1998057651A1 (en) * 1997-06-18 1998-12-23 Discovery Therapeutics, Inc. Compositions and methods for preventing restenosis following revascularization procedures
JPH11335302A (ja) * 1998-05-26 1999-12-07 Toa Eiyo Ltd 安定な医薬組成物
JP3619017B2 (ja) * 1998-06-24 2005-02-09 日本臓器製薬株式会社 新規アラビノシルアデニン誘導体
JP2002173427A (ja) * 1998-09-01 2002-06-21 Yamasa Shoyu Co Ltd 眼疾患治療用医薬組成物

Also Published As

Publication number Publication date
SK10972001A3 (sk) 2002-01-07
IL144188A (en) 2008-12-29
EP1150991A2 (en) 2001-11-07
MXPA01007850A (es) 2002-08-20
DE60009665D1 (de) 2004-05-13
HK1047288A1 (en) 2003-02-14
JP2002536300A (ja) 2002-10-29
WO2000044763A3 (en) 2000-12-14
EP1150991B1 (en) 2004-04-07
CN1191266C (zh) 2005-03-02
WO2000044763A2 (en) 2000-08-03
MY129445A (en) 2007-04-30
AU2005201255A1 (en) 2005-04-21
IL144188A0 (en) 2002-05-23
NO20013507D0 (no) 2001-07-13
AR029332A1 (es) 2003-06-25
AU2005201255B2 (en) 2008-02-28
BR0007864A (pt) 2001-11-06
KR100668006B1 (ko) 2007-01-15
EE200100397A (et) 2002-08-15
HU228937B1 (en) 2013-06-28
PT1150991E (pt) 2004-08-31
CZ296404B6 (cs) 2006-03-15
CA2361614E (en) 2000-08-03
CN1357002A (zh) 2002-07-03
DK1150991T3 (da) 2004-06-07
AU2745400A (en) 2000-08-18
NZ513096A (en) 2003-01-31
JP4837831B2 (ja) 2011-12-14
DE60009665T2 (de) 2004-08-19
UA72912C2 (uk) 2005-05-16
CZ20012781A3 (cs) 2002-01-16
CA2361614C (en) 2008-08-26
NO321216B1 (no) 2006-04-03
ES2215609T3 (es) 2004-10-16
HUP0200224A2 (en) 2002-06-29
SK284877B6 (sk) 2006-01-05
KR20020013494A (ko) 2002-02-20
HUP0200224A3 (en) 2005-02-28
ATE263777T1 (de) 2004-04-15
AU778870B2 (en) 2004-12-23
CA2361614A1 (en) 2000-08-03
NO20013507L (no) 2001-09-18
PL199953B1 (pl) 2008-11-28

Similar Documents

Publication Publication Date Title
NO2021009I1 (no) XARELTO - forlenget SPC
EE05185B1 (et) Kompositsioonid p?letikuliste protsesside k„sitlemiseks
DE60013221D1 (de) Fotopolymerisierbare Zusammensetzung
DE60207390D1 (de) Entzündungshemmende benzimidazolverbindungen
AR023440A1 (es) Composiciones antitranspirantes
DE60031024D1 (de) Fluorkautschukzusammensetzungen
DE60028268D1 (de) Fluorkautschukzusammensetzungen
IS6120A (is) Lyfjablanda
PT1181017E (pt) Inibidores de metaloproteases
PT1224195E (pt) C-aril-glicosidos inibidores de tgls2
NO20014608L (no) Vekstfremmende sammensetninger
PT1206182E (pt) Composicoes herbicidas
DE60033373D1 (de) Flammgeschützte polyolefinzusammensetzungen
DE69922267D1 (de) Bewegliches zusammensetzspiel
ID29785A (id) Komposisi-komposisi sampo
PT1194404E (pt) Inibidores de aspartil-protease
ATE305470T1 (de) Naphthyridinverbindungen
ATE257691T1 (de) Schweisshemmende zusammensetzungen
FI20002884A0 (fi) Elastomeerien polyalfaolefiinipehmittimet
DE60014955D1 (de) Schraubzange
DE19917146B4 (de) Nullpunktspannsystem
NO20013769D0 (no) Kalsilytiske forbindelser
DE60106131D1 (de) Handhabungssystem für Gegenstände
DE60000022D1 (de) Verbesserte teilchenförmige Zusammensetzungen
DE50012945D1 (de) Transportpalette

Legal Events

Date Code Title Description
LD4A Amendment in the specification
KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20180131